Your search returned 6 results.

Results
	1.	First large, multicenter, open-label study utilizing HLA-B*5701 screening for abacavir hypersensitivity in North America. [electronic resource] by Young, Benjamin Squires, Kathleen Patel, Parul Dejesus, Edwin Bellos, Nicholaos Berger, Daniel Sutherland-Phillips, Denise H Liao, Qiming Shaefer, Mark Wannamaker, Paul Producer: 20080924 In: AIDS (London, England) vol. 22 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment. [electronic resource] by Smith, Kimberly Y Patel, Parul Fine, Derek Bellos, Nicholaos Sloan, Louis Lackey, Philip Kumar, Princy N Sutherland-Phillips, Denise H Vavro, Cindy Yau, Linda Wannamaker, Paul Shaefer, Mark S Producer: 20091015 In: AIDS (London, England) vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Short-term safety and tolerability of a once-daily fixed-dose abacavir-lamivudine combination versus twice-daily dosing of abacavir and lamivudine as separate components: findings from the ALOHA study. [electronic resource] by Cohen, Calvin J Kubota, Marshall Brachman, Philip S Harley, William B Schneider, Stefan Williams, Vanessa C Sutherland-Phillips, Denise H Lim, Michael L Balu, Rukmini B Shaefer, Mark S Producer: 20080603 In: Pharmacotherapy vol. 28 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	High sensitivity of human leukocyte antigen-b*5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients. [electronic resource] by Saag, Michael Balu, Rukmini Phillips, Elizabeth Brachman, Philip Martorell, Claudia Burman, William Stancil, Britt Mosteller, Michael Brothers, Cindy Wannamaker, Paul Hughes, Arlene Sutherland-Phillips, Denise Mallal, Simon Shaefer, Mark Producer: 20080617 In: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. 46 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Safety and efficacy of a 36-week induction regimen of abacavir/lamivudine and ritonavir-boosted atazanavir in HIV-infected patients. [electronic resource] by Squires, Kathleen E Young, Benjamin DeJesus, Edwin Bellos, Nicholas Murphy, Daniel Sutherland-Phillips, Denise H Zhao, Henry H Patel, Lisa G Ross, Lisa L Wannamaker, Paul G Shaefer, Mark S Producer: 20100727 In: HIV clinical trials vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial. [electronic resource] by Eron, Joseph Yeni, Patrick Gathe, Joseph Estrada, Vicente DeJesus, Edwin Staszewski, Schlomo Lackey, Philip Katlama, Christine Young, Benjamin Yau, Linda Sutherland-Phillips, Denise Wannamaker, Paul Vavro, Cindy Patel, Lisa Yeo, Jane Shaefer, Mark Producer: 20060822 In: Lancet (London, England) vol. 368 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)